Cargando…

Low Levels of Plasma Osteoglycin in Patients with Complex Coronary Lesions

Aim: Osteoglycin is one of proteoglycans that are biologically active components of vascular extracellular matrix. However, the role of osteoglycin in atherosclerosis remains unclear. Methods: We investigated plasma osteoglycin levels and the presence, severity, and lesion morphology of coronary art...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seki, Toshiki, Saita, Emi, Kishimoto, Yoshimi, Ibe, Susumu, Miyazaki, Yoshichika, Miura, Kotaro, Ohmori, Reiko, Ikegami, Yukinori, Kondo, Kazuo, Momiyama, Yukihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224206/ https://www.ncbi.nlm.nih.gov/pubmed/29503411 http://dx.doi.org/10.5551/jat.43059

Ejemplares similares

Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease
por: Miyazaki, Yoshichika, et al.
Publicado: (2018)

Associations Between Plasma Betatrophin Levels and Coronary and Peripheral Artery Disease
por: Niki, Hanako, et al.
Publicado: (2019)

Plasma Heme Oxygenase-1 Levels in Patients with Coronary and Peripheral Artery Diseases
por: Kishimoto, Yoshimi, et al.
Publicado: (2018)

Association between Plasma Sestrin2 Levels and the Presence and Severity of Coronary Artery Disease
por: Kishimoto, Yoshimi, et al.
Publicado: (2020)

Associations Between Plasma Kinin B1 Receptor Levels and the Presence and Severity of Coronary Artery Disease
por: Kishimoto, Yoshimi, et al.
Publicado: (2021)

High Plasma Levels of Legumain in Patients with Complex Coronary Lesions
por: Umei, Tomohiko C., et al.
Publicado: (2020)

Plasma interleukin-27 levels in patients with coronary artery disease
por: Miura, Kotaro, et al.
Publicado: (2017)

High Plasma Levels of Soluble Talin-1 in Patients with Coronary Artery Disease
por: Aoyama, Masayuki, et al.
Publicado: (2020)

Association between the Japanese Diet and Coronary Artery Disease in Patients Undergoing Coronary Angiography
por: Momiyama, Yukihiko, et al.
Publicado: (2023)

Low Plasma Levels of Soluble Endoglin and Cardiovascular Events in Patients Undergoing Coronary Angiography
por: Saita, Emi, et al.
Publicado: (2023)

Plasma Betatrophin Levels and Carotid Atherosclerosis
por: Niki, Hanako, et al.
Publicado: (2019)

No Significant Association Between Plasma Endosialin Levels and the Presence or Severity of Coronary Artery Disease
por: Kishimoto, Yoshimi, et al.
Publicado: (2022)

High Plasma Levels of Fortilin in Patients with Coronary Artery Disease
por: Aoyama, Masayuki, et al.
Publicado: (2022)

Plasma Concentrations of Vinculin versus Talin-1 in Coronary Artery Disease
por: Aoyama, Masayuki, et al.
Publicado: (2022)

Anti-Inflammatory Diet for Atherosclerosis and Coronary Artery Disease: Antioxidant Foods
por: Saita, Emi, et al.
Publicado: (2015)

Antioxidant Beverages: Green Tea Intake and Coronary Artery Disease
por: Ohmori, Reiko, et al.
Publicado: (2014)

Syncope Due to a Free-floating Left Atrial Thrombus
por: Miura, Kotaro, et al.
Publicado: (2017)

The Protective Role of Heme Oxygenase-1 in Atherosclerotic Diseases
por: Kishimoto, Yoshimi, et al.
Publicado: (2019)

The Protective Role of Sestrin2 in Atherosclerotic and Cardiac Diseases
por: Kishimoto, Yoshimi, et al.
Publicado: (2021)

Inflammation, Atherosclerosis and Coronary Artery Disease
por: Momiyama, Yukihiko, et al.
Publicado: (2016)

The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis
por: Kampmann, Andreas, et al.
Publicado: (2008)

Osteoglycin: An ECM Factor Regulating Fibrosis and Tumorigenesis
por: Nulali, Jiayida, et al.
Publicado: (2022)

Osteoglycin, a novel coordinator of bone and glucose homeostasis
por: Lee, N.J., et al.
Publicado: (2018)

Osteoglycin – A switch from angiogenesis to T-cell recruitment?
por: Dimberg, Anna
Publicado: (2018)

Estimated Dietary Polyphenol Intake and Major Food and Beverage Sources among Elderly Japanese
por: Taguchi, Chie, et al.
Publicado: (2015)

Associations between LDL/HDL-cholesterol ratio and thoracic and abdominal aortic atherosclerosis assessed by MRI
por: Momiyama, Yukihiko, et al.
Publicado: (2012)

Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs
por: Chen, Xia, et al.
Publicado: (2017)

Terminalia bellirica Extract Inhibits Low-Density Lipoprotein Oxidation and Macrophage Inflammatory Response in Vitro
por: Tanaka, Miori, et al.
Publicado: (2016)

Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer
por: Hu, Xiang, et al.
Publicado: (2018)

C/EBPβ LIP augments cell death by inducing osteoglycin
por: Wassermann-Dozorets, Rina, et al.
Publicado: (2017)

Osteoglycin inhibition by microRNA miR-155 impairs myogenesis
por: Freire, Paula Paccielli, et al.
Publicado: (2017)

Associations of Circulating Osteoglycin With Bone Parameters and Metabolic Markers in Patients With Diabetes
por: Starup-Linde, Jakob Kau, et al.
Publicado: (2021)

Sweet potato (Ipomoea batatas L.) leaves suppressed oxidation of low density lipoprotein (LDL) in vitro and in human subjects
por: Nagai, Miu, et al.
Publicado: (2011)

Associations of plasma C-Reactive Protein and osteopontin levels with the severities of coronary and aortic atherosclerosis
por: Momiyama, Yukihiko, et al.
Publicado: (2009)

Vertebrate SLRP family evolution and the subfunctionalization of osteoglycin gene duplicates in teleost fish
por: Costa, R. A., et al.
Publicado: (2018)

Aronia berry extract inhibits TNF-α-induced vascular endothelial inflammation through the regulation of STAT3
por: Iwashima, Tomomi, et al.
Publicado: (2019)

Serum levels of iCAF‐derived osteoglycin predict favorable outcome in pancreatic cancer
por: Dings, Mark P. G., et al.
Publicado: (2022)

Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling
por: Mei, Yu, et al.
Publicado: (2017)

Osteoglycin as a Potential Biomarker of Mild Kidney Function Impairment in Type 2 Diabetes Patients
por: González-Salvatierra, Sheila, et al.
Publicado: (2021)

Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
por: Hu, Xiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a4qu2ib0h0rmmtamg0sn0m8o5g